Research landmarks on the 60th anniversary of Epstein-Barr virus
Authors:
- 4 November 2024
- journal article
- review article
- Published by Springer Nature in Science China Life Sciences
- Vol. 68 (2) , 354-380
Abstract
Epstein-Barr virus (EBV), the first human oncovirus discovered in 1964, has become a focal point in virology, immunology, and oncology because of its unique biological characteristics and significant role in human diseases. As we commemorate the 60th anniversary of EBV’s discovery, it is an opportune moment to reflect on the major advancements in our understanding of this complex virus. In this review, we highlight key milestones in EBV research, including its virion structure and life cycle, interactions with the host immune system, association with EBV-associated diseases, and targeted intervention strategies.Keywords
This publication has 384 references indexed in Scilit:
- mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in MiceAdvanced Science, 2023
- EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2022
- Does This Patient Have Infectious Mononucleosis?JAMA, 2016
- Epstein–Barr virus presence in pediatric diffuse large B‐cell lymphoma reveals a particular association and latency patterns: Analysis of viral role in tumor microenvironmentInternational Journal of Cancer, 2012
- Primary infection with the Epstein‐Barr virus and risk of multiple sclerosisAnnals of Neurology, 2010
- Epstein‐Barr virus promotes interferon‐α production by plasmacytoid dendritic cellsArthritis & Rheumatism, 2010
- STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitroInternational Journal of Cancer, 2009
- Spatial clustering of endemic Burkitt's lymphoma in high‐risk regions of KenyaInternational Journal of Cancer, 2006
- Epstein‐Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real‐time polymerase chain reactionArthritis & Rheumatism, 2003
- Identification and prevalence of CD8+ T‐cell responses directed against Epstein‐Barr virus‐encoded latent membrane protein 1 and latent membrane protein 2International Journal of Cancer, 2002